BPC-157 and TB-500 are the two most-studied recovery peptides, and researchers often compare — or combine — them. The short version: BPC-157 is most associated with localized tissue-repair and gastrointestinal research, while TB-500 is studied for systemic cell migration and flexibility. They act through different mechanisms, which is exactly why they are frequently co-studied.
BPC-157 in research
BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric protein sequence. In preclinical models it is studied for tissue repair, tendon and ligament research, angiogenesis, and gastrointestinal protection — often for effects observed near the site of application.
TB-500 in research
TB-500 is a synthetic fragment of the actin-binding protein thymosin beta-4. Research focuses on cell migration, actin regulation, and systemic recovery models — a broader, whole-system emphasis compared with BPC-157.
Key research differences
| Class | BPC-157: gastric-derived peptide · TB-500: thymosin β-4 fragment |
|---|---|
| Research emphasis | BPC-157: localized repair, GI · TB-500: systemic cell migration |
| Mechanism studied | BPC-157: angiogenesis/growth pathways · TB-500: actin binding |
Studied together
Because their mechanisms differ, the two are commonly researched as a pair — available as the BPC-157 + TB-500 blend. Both ship lyophilized; reconstitute with bacteriostatic water (see our reconstitution guide).
Why researchers buy from Miami Peptide Lab
- 99%+ purity, lab-tested every lot — COA available on request
- Ships from Miami / the US in 24–48h, discreet cold-chain packaging
- Buy-more-save-more bundle pricing, and a reship-or-refund guarantee
Research Use Only. All compounds are sold strictly for laboratory research and are not for human or animal consumption, nor for therapeutic, diagnostic, or cosmetic use.
